BML Capital Management LLC reduced its stake in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 27.0% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,157,179 shares of the biotechnology company’s stock after selling 1,910,000 shares during the period. Adverum Biotechnologies makes up […]
DURECT Co. (NASDAQ:DRRX – Get Free Report) was the target of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 2,170,000 shares, a growth of 19.2% from the August 15th total of 1,820,000 shares. Currently, 8.0% of the shares of the company are sold […]
StockNews com Initiates Coverage on Pieris Pharmaceuticals (NASDAQ:PIRS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Commodore Capital LP acquired a new position in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 5,000,000 shares of the biotechnology company’s stock, valued at approximately $3,587,000. Adverum Biotechnologies accounts for 0.5% […]
Affinity Asset Advisors LLC trimmed its position in shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Free Report) by 5.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,083,118 shares of the biopharmaceutical company’s stock after selling 60,413 shares during the quarter. CymaBay Therapeutics […]